APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Bacterial Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Human Bacterial Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025186 pages

Choose your research edition.

Industry ResearchHuman Bacterial Vaccine Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Bacterial Vaccine Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Human Bacterial Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Bacterial Vaccine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Bacterial Vaccine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Human Bacterial Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Human Bacterial Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Human Bacterial Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Bacterial Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Human Bacterial Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Bacterial Vaccine include Emergent BioSolutions, Mitsubishi Tanabe Pharma, Bayer, GSK, Pfizer, Merck and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Human Bacterial Vaccine market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Human Bacterial Vaccine and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human Bacterial Vaccine revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Human Bacterial Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Human Bacterial Vaccine Segment by Company

Emergent BioSolutions

Mitsubishi Tanabe Pharma

Bayer

GSK

Pfizer

Merck

Sanofi

Human Bacterial Vaccine Segment by Type

Bacillus Anthracis

Haemophilus Influenzae

Salmonella Typhi

Clostridium Tetani

Streptococcus Pneumoniae

Pertussis

Others

Human Bacterial Vaccine Segment by Application

Elderly

Children

Adults

Human Bacterial Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Bacterial Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Bacterial Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Bacterial Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Human Bacterial Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Human Bacterial Vaccine industry.

Chapter 3: Detailed analysis of Human Bacterial Vaccine companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Bacterial Vaccinerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Human Bacterial Vaccine Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Bacillus Anthracis Table 3. Key Players of Haemophilus Influenzae Table 4. Key Players of Salmonella Typhi Table 3. Key Players of Clostridium Tetani Table 4. Key Players of Streptococcus Pneumoniae Table 5. Key Players of Pertussis Table 6. Key Players of Others Table 7. Global Human Bacterial Vaccine Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 8. Key Players of Elderly Table 9. Key Players of Children Table 10. Key Players of Adults Table 11. Global Human Bacterial Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Human Bacterial Vaccine Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Human Bacterial Vaccine Market Share by Region (2021-2026) Table 14. Global Human Bacterial Vaccine Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Human Bacterial Vaccine Market Share by Region (2027-2032) Table 16. Human Bacterial Vaccine Industry Trends Table 17. Human Bacterial Vaccine Industry Drivers Table 18. Human Bacterial Vaccine Industry Opportunities and Challenges Table 19. Human Bacterial Vaccine Industry Restraints Table 20. Global Human Bacterial Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 21. Global Human Bacterial Vaccine Revenue Market Share by Company (2021-2026) Table 22. Global Human Bacterial Vaccine Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 23. Global Human Bacterial Vaccine Key Company Head Office and Area Served Table 24. Global Human Bacterial Vaccine Company, Product Type & Application Table 25. Global Human Bacterial Vaccine Company Establishment Date Table 26. Global Company Market Concentration Ratio (CR5 and HHI) Table 27. Global Human Bacterial Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 28. Global Human Bacterial Vaccine Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Human Bacterial Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 30. Global Human Bacterial Vaccine Market Size by Type (2027-2032) & (US$ Million) Table 31. Global Human Bacterial Vaccine Revenue Market Share by Type (2021-2026) Table 32. Global Human Bacterial Vaccine Revenue Market Share by Type (2027-2032) Table 33. Global Human Bacterial Vaccine Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Human Bacterial Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 35. Global Human Bacterial Vaccine Market Size by Application (2027-2032) & (US$ Million) Table 36. Global Human Bacterial Vaccine Revenue Market Share by Application (2021-2026) Table 37. Global Human Bacterial Vaccine Revenue Market Share by Application (2027-2032) Table 38. Emergent BioSolutions Company Information Table 39. Emergent BioSolutions Business Overview Table 40. Emergent BioSolutions Human Bacterial Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Emergent BioSolutions Human Bacterial Vaccine Product Portfolio Table 42. Emergent BioSolutions Recent Development Table 43. Mitsubishi Tanabe Pharma Company Information Table 44. Mitsubishi Tanabe Pharma Business Overview Table 45. Mitsubishi Tanabe Pharma Human Bacterial Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Mitsubishi Tanabe Pharma Human Bacterial Vaccine Product Portfolio Table 47. Mitsubishi Tanabe Pharma Recent Development Table 48. Bayer Company Information Table 49. Bayer Business Overview Table 50. Bayer Human Bacterial Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Bayer Human Bacterial Vaccine Product Portfolio Table 52. Bayer Recent Development Table 53. GSK Company Information Table 54. GSK Business Overview Table 55. GSK Human Bacterial Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. GSK Human Bacterial Vaccine Product Portfolio Table 57. GSK Recent Development Table 58. Pfizer Company Information Table 59. Pfizer Business Overview Table 60. Pfizer Human Bacterial Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Pfizer Human Bacterial Vaccine Product Portfolio Table 62. Pfizer Recent Development Table 63. Merck Company Information Table 64. Merck Business Overview Table 65. Merck Human Bacterial Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Merck Human Bacterial Vaccine Product Portfolio Table 67. Merck Recent Development Table 68. Sanofi Company Information Table 69. Sanofi Business Overview Table 70. Sanofi Human Bacterial Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Sanofi Human Bacterial Vaccine Product Portfolio Table 72. Sanofi Recent Development Table 73. North America Human Bacterial Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 74. North America Human Bacterial Vaccine Market Size by Type (2027-2032) & (US$ Million) Table 75. North America Human Bacterial Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 76. North America Human Bacterial Vaccine Market Size by Application (2027-2032) & (US$ Million) Table 77. North America Human Bacterial Vaccine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 78. North America Human Bacterial Vaccine Market Size by Country (2021-2026) Table 79. North America Human Bacterial Vaccine Market Size by Country (2027-2032) Table 80. Europe Human Bacterial Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 81. Europe Human Bacterial Vaccine Market Size by Type (2027-2032) & (US$ Million) Table 82. Europe Human Bacterial Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 83. Europe Human Bacterial Vaccine Market Size by Application (2027-2032) & (US$ Million) Table 84. Europe Human Bacterial Vaccine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. Europe Human Bacterial Vaccine Market Size by Country (2021-2026) Table 86. Europe Human Bacterial Vaccine Market Size by Country (2027-2032) Table 87. China Human Bacterial Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 88. China Human Bacterial Vaccine Market Size by Type (2027-2032) & (US$ Million) Table 89. China Human Bacterial Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 90. China Human Bacterial Vaccine Market Size by Application (2027-2032) & (US$ Million) Table 91. Asia Human Bacterial Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 92. Asia Human Bacterial Vaccine Market Size by Type (2027-2032) & (US$ Million) Table 93. Asia Human Bacterial Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 94. Asia Human Bacterial Vaccine Market Size by Application (2027-2032) & (US$ Million) Table 95. Asia Human Bacterial Vaccine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. Asia Human Bacterial Vaccine Market Size by Country (2021-2026) Table 97. Asia Human Bacterial Vaccine Market Size by Country (2027-2032) Table 98. South America, Middle East & Africa Human Bacterial Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 99. South America, Middle East & Africa Human Bacterial Vaccine Market Size by Type (2027-2032) & (US$ Million) Table 100. South America, Middle East & Africa Human Bacterial Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 101. South America, Middle East & Africa Human Bacterial Vaccine Market Size by Application (2027-2032) & (US$ Million) Table 102. South America, Middle East & Africa Human Bacterial Vaccine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. South America, Middle East & Africa Human Bacterial Vaccine Market Size by Country (2021-2026) Table 104. South America, Middle East & Africa Human Bacterial Vaccine Market Size by Country (2027-2032) Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Human Bacterial Vaccine Product Image Figure 2. Global Human Bacterial Vaccine Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Human Bacterial Vaccine Market Share by Type: 2025 VS 2032 Figure 4. Bacillus Anthracis Image Figure 5. Haemophilus Influenzae Image Figure 6. Salmonella Typhi Image Figure 7. Clostridium Tetani Image Figure 8. Streptococcus Pneumoniae Image Figure 9. Pertussis Image Figure 10. Others Image Figure 11. Global Human Bacterial Vaccine Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 12. Global Human Bacterial Vaccine Market Share by Application: 2025 VS 2032 Figure 13. Elderly Image Figure 14. Children Image Figure 15. Adults Image Figure 16. Global Human Bacterial Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Human Bacterial Vaccine Market Size (2021-2032) & (US$ Million) Figure 18. Global Human Bacterial Vaccine Market Share by Region: 2025 VS 2032 Figure 19. Years Considered Figure 20. Global Human Bacterial Vaccine Market Share by Players in 2025 Figure 21. Global Top 5 and 10 Human Bacterial Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Human Bacterial Vaccine Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Human Bacterial Vaccine Revenue Market Share by Type (2021-2032) Figure 25. Global Human Bacterial Vaccine Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Human Bacterial Vaccine Revenue Market Share by Application (2021-2032) Figure 27. North America Human Bacterial Vaccine Market Size (2021-2032) & (US$ Million) Figure 28. North America Human Bacterial Vaccine Market Share by Type (2021-2032) Figure 29. North America Human Bacterial Vaccine Market Share by Application (2021-2032) Figure 30. North America Human Bacterial Vaccine Market Share by Country (2021-2032) Figure 31. United States Human Bacterial Vaccine Market Size (2021-2032) & (US$ Million) Figure 32. Canada Human Bacterial Vaccine Market Size (2021-2032) & (US$ Million) Figure 33. Mexico Human Bacterial Vaccine Market Size (2021-2032) & (US$ Million) Figure 34. Europe Human Bacterial Vaccine Market Size (2021-2032) & (US$ Million) Figure 35. Europe Human Bacterial Vaccine Market Share by Type (2021-2032) Figure 36. Europe Human Bacterial Vaccine Market Share by Application (2021-2032) Figure 37. Europe Human Bacterial Vaccine Market Share by Country (2021-2032) Figure 38. Germany Human Bacterial Vaccine Market Size (2021-2032) & (US$ Million) Figure 39. France Human Bacterial Vaccine Market Size (2021-2032) & (US$ Million) Figure 40. U.K. Human Bacterial Vaccine Market Size (2021-2032) & (US$ Million) Figure 41. Italy Human Bacterial Vaccine Market Size (2021-2032) & (US$ Million) Figure 42. Russia Human Bacterial Vaccine Market Size (2021-2032) & (US$ Million) Figure 43. Nordic Countries Human Bacterial Vaccine Market Size (2021-2032) & (US$ Million) Figure 44. China Human Bacterial Vaccine Market Size (2021-2032) & (US$ Million) Figure 45. China Human Bacterial Vaccine Market Share by Type (2021-2032) Figure 46. China Human Bacterial Vaccine Market Share by Application (2021-2032) Figure 47. Asia Human Bacterial Vaccine Market Size (2021-2032) & (US$ Million) Figure 48. Asia Human Bacterial Vaccine Market Share by Type (2021-2032) Figure 49. Asia Human Bacterial Vaccine Market Share by Application (2021-2032) Figure 50. Asia Human Bacterial Vaccine Market Share by Country (2021-2032) Figure 51. Japan Human Bacterial Vaccine Market Size (2021-2032) & (US$ Million) Figure 52. South Korea Human Bacterial Vaccine Market Size (2021-2032) & (US$ Million) Figure 53. Taiwan Human Bacterial Vaccine Market Size (2021-2032) & (US$ Million) Figure 54. Southeast Asia Human Bacterial Vaccine Market Size (2021-2032) & (US$ Million) Figure 55. India Human Bacterial Vaccine Market Size (2021-2032) & (US$ Million) Figure 56. Australia Human Bacterial Vaccine Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Human Bacterial Vaccine Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa Human Bacterial Vaccine Market Share by Type (2021-2032) Figure 59. South America, Middle East & Africa Human Bacterial Vaccine Market Share by Application (2021-2032) Figure 60. South America, Middle East & Africa Human Bacterial Vaccine Market Share by Country (2021-2032) Figure 61. Brazil Human Bacterial Vaccine Market Size (2021-2032) & (US$ Million) Figure 62. South Africa Human Bacterial Vaccine Market Size (2021-2032) & (US$ Million) Figure 63. Saudi Arabia Human Bacterial Vaccine Market Size (2021-2032) & (US$ Million) Figure 64. Turkey Human Bacterial Vaccine Market Size (2021-2032) & (US$ Million) Figure 65. Argentina Human Bacterial Vaccine Market Size (2021-2032) & (US$ Million) Figure 66. UAE Human Bacterial Vaccine Market Size (2021-2032) & (US$ Million) Figure 67. Egypt Human Bacterial Vaccine Market Size (2021-2032) & (US$ Million) Figure 68. Chile Human Bacterial Vaccine Market Size (2021-2032) & (US$ Million) Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Bacillus Anthracis
  • Haemophilus Influenzae
  • Salmonella Typhi
  • Clostridium Tetani
  • Streptococcus Pneumoniae
  • Pertussis
  • Others
Applications
  • Elderly
  • Children
  • Adults
Companies covered
  • Emergent BioSolutions
  • Mitsubishi Tanabe Pharma
  • Bayer
  • GSK
  • Pfizer
  • Merck
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Human Bacterial Vaccine Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Bacillus Anthracis
  5. 1.2.3 Haemophilus Influenzae
  6. 1.2.4 Salmonella Typhi
  7. 1.2.5 Clostridium Tetani
  8. 1.2.6 Streptococcus Pneumoniae
  9. 1.2.7 Pertussis
  10. 1.2.8 Others
  11. 1.3 Market Analysis by Application
  12. 1.3.1 Global Human Bacterial Vaccine Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  13. 1.3.2 Elderly
  14. 1.3.3 Children
  15. 1.3.4 Adults
  16. 1.4 Global Market Growth Prospects
  17. 1.5 Global Human Bacterial Vaccine Growth Trends by Region
  18. 1.5.1 Global Human Bacterial Vaccine Market Size by Region: 2021 VS 2025 VS 2032
  19. 1.5.2 Human Bacterial Vaccine Market Size by Region (2021-2026)
  20. 1.5.3 Human Bacterial Vaccine Market Size by Region (2027-2032)
  21. 1.6 Assumptions and Limitations
  22. 1.7 Study Goals and Objectives
  23. 1.8 Years Considered
2 Global Human Bacterial Vaccine Market Dynamics
  1. 2.1 Human Bacterial Vaccine Industry Trends
  2. 2.2 Human Bacterial Vaccine Industry Drivers
  3. 2.3 Human Bacterial Vaccine Industry Opportunities and Challenges
  4. 2.4 Human Bacterial Vaccine Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Human Bacterial Vaccine Revenue by Company (2021-2026)
  2. 3.2 Global Human Bacterial Vaccine Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Human Bacterial Vaccine Key Company Head office and Area Served
  4. 3.4 Global Human Bacterial Vaccine Company, Product Type & Application
  5. 3.5 Global Human Bacterial Vaccine Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Human Bacterial Vaccine Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Human Bacterial Vaccine Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Human Bacterial Vaccine Tier 1, Tier 2, and Tier 3
4 Human Bacterial Vaccine Market by Type
  1. 4.1 Global Human Bacterial Vaccine Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Human Bacterial Vaccine Market Size by Type (2021-2032)
  3. 4.3 Global Human Bacterial Vaccine Market Size Share by Type (2021-2032)
5 Human Bacterial Vaccine Market by Application
  1. 5.1 Global Human Bacterial Vaccine Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Human Bacterial Vaccine Market Size by Application (2021-2032)
  3. 5.3 Global Human Bacterial Vaccine Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Emergent BioSolutions
  2. 6.1.1 Emergent BioSolutions Company Information
  3. 6.1.2 Emergent BioSolutions Business Overview
  4. 6.1.3 Emergent BioSolutions Human Bacterial Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Emergent BioSolutions Human Bacterial Vaccine Product Portfolio
  6. 6.1.5 Emergent BioSolutions Recent Developments
  7. 6.2 Mitsubishi Tanabe Pharma
  8. 6.2.1 Mitsubishi Tanabe Pharma Company Information
  9. 6.2.2 Mitsubishi Tanabe Pharma Business Overview
  10. 6.2.3 Mitsubishi Tanabe Pharma Human Bacterial Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Mitsubishi Tanabe Pharma Human Bacterial Vaccine Product Portfolio
  12. 6.2.5 Mitsubishi Tanabe Pharma Recent Developments
  13. 6.3 Bayer
  14. 6.3.1 Bayer Company Information
  15. 6.3.2 Bayer Business Overview
  16. 6.3.3 Bayer Human Bacterial Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Bayer Human Bacterial Vaccine Product Portfolio
  18. 6.3.5 Bayer Recent Developments
  19. 6.4 GSK
  20. 6.4.1 GSK Company Information
  21. 6.4.2 GSK Business Overview
  22. 6.4.3 GSK Human Bacterial Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 GSK Human Bacterial Vaccine Product Portfolio
  24. 6.4.5 GSK Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Human Bacterial Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Pfizer Human Bacterial Vaccine Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 Merck
  32. 6.6.1 Merck Company Information
  33. 6.6.2 Merck Business Overview
  34. 6.6.3 Merck Human Bacterial Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Merck Human Bacterial Vaccine Product Portfolio
  36. 6.6.5 Merck Recent Developments
  37. 6.7 Sanofi
  38. 6.7.1 Sanofi Company Information
  39. 6.7.2 Sanofi Business Overview
  40. 6.7.3 Sanofi Human Bacterial Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Sanofi Human Bacterial Vaccine Product Portfolio
  42. 6.7.5 Sanofi Recent Developments
7 North America
  1. 7.1 North America Human Bacterial Vaccine Market Size (2021-2032)
  2. 7.2 North America Human Bacterial Vaccine Market Size by Type
  3. 7.2.1 North America Human Bacterial Vaccine Market Size by Type (2021-2026)
  4. 7.2.2 North America Human Bacterial Vaccine Market Size by Type (2027-2032)
  5. 7.2.3 North America Human Bacterial Vaccine Market Share by Type (2021-2032)
  6. 7.3 North America Human Bacterial Vaccine Market Size by Application
  7. 7.3.1 North America Human Bacterial Vaccine Market Size by Application (2021-2026)
  8. 7.3.2 North America Human Bacterial Vaccine Market Size by Application (2027-2032)
  9. 7.3.3 North America Human Bacterial Vaccine Market Share by Application (2021-2032)
  10. 7.4 North America Human Bacterial Vaccine Market Size by Country
  11. 7.4.1 North America Human Bacterial Vaccine Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Human Bacterial Vaccine Market Size by Country (2021-2026)
  13. 7.4.3 North America Human Bacterial Vaccine Market Size by Country (2027-2032)
  14. 7.4.4 North America Human Bacterial Vaccine Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Human Bacterial Vaccine Market Size (2021-2032)
  2. 8.2 Europe Human Bacterial Vaccine Market Size by Type
  3. 8.2.1 Europe Human Bacterial Vaccine Market Size by Type (2021-2026)
  4. 8.2.2 Europe Human Bacterial Vaccine Market Size by Type (2027-2032)
  5. 8.2.3 Europe Human Bacterial Vaccine Market Share by Type (2021-2032)
  6. 8.3 Europe Human Bacterial Vaccine Market Size by Application
  7. 8.3.1 Europe Human Bacterial Vaccine Market Size by Application (2021-2026)
  8. 8.3.2 Europe Human Bacterial Vaccine Market Size by Application (2027-2032)
  9. 8.3.3 Europe Human Bacterial Vaccine Market Share by Application (2021-2032)
  10. 8.4 Europe Human Bacterial Vaccine Market Size by Country
  11. 8.4.1 Europe Human Bacterial Vaccine Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Human Bacterial Vaccine Market Size by Country (2021-2026)
  13. 8.4.3 Europe Human Bacterial Vaccine Market Size by Country (2027-2032)
  14. 8.4.4 Europe Human Bacterial Vaccine Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Human Bacterial Vaccine Market Size (2021-2032)
  2. 9.2 China Human Bacterial Vaccine Market Size by Type
  3. 9.2.1 China Human Bacterial Vaccine Market Size by Type (2021-2026)
  4. 9.2.2 China Human Bacterial Vaccine Market Size by Type (2027-2032)
  5. 9.2.3 China Human Bacterial Vaccine Market Share by Type (2021-2032)
  6. 9.3 China Human Bacterial Vaccine Market Size by Application
  7. 9.3.1 China Human Bacterial Vaccine Market Size by Application (2021-2026)
  8. 9.3.2 China Human Bacterial Vaccine Market Size by Application (2027-2032)
  9. 9.3.3 China Human Bacterial Vaccine Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Human Bacterial Vaccine Market Size (2021-2032)
  2. 10.2 Asia Human Bacterial Vaccine Market Size by Type
  3. 10.2.1 Asia Human Bacterial Vaccine Market Size by Type (2021-2026)
  4. 10.2.2 Asia Human Bacterial Vaccine Market Size by Type (2027-2032)
  5. 10.2.3 Asia Human Bacterial Vaccine Market Share by Type (2021-2032)
  6. 10.3 Asia Human Bacterial Vaccine Market Size by Application
  7. 10.3.1 Asia Human Bacterial Vaccine Market Size by Application (2021-2026)
  8. 10.3.2 Asia Human Bacterial Vaccine Market Size by Application (2027-2032)
  9. 10.3.3 Asia Human Bacterial Vaccine Market Share by Application (2021-2032)
  10. 10.4 Asia Human Bacterial Vaccine Market Size by Country
  11. 10.4.1 Asia Human Bacterial Vaccine Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Human Bacterial Vaccine Market Size by Country (2021-2026)
  13. 10.4.3 Asia Human Bacterial Vaccine Market Size by Country (2027-2032)
  14. 10.4.4 Asia Human Bacterial Vaccine Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Human Bacterial Vaccine Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Human Bacterial Vaccine Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Human Bacterial Vaccine Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Human Bacterial Vaccine Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Human Bacterial Vaccine Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Human Bacterial Vaccine Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Human Bacterial Vaccine Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Human Bacterial Vaccine Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Human Bacterial Vaccine Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Human Bacterial Vaccine Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Human Bacterial Vaccine Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Human Bacterial Vaccine Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Human Bacterial Vaccine Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Human Bacterial Vaccine Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst